The main purpose of this legislation is to ensure that Medicare provides clear guidance on how it will cover certain medical devices that use artificial intelligence. Specifically, it aims to address the payment process for remote monitoring devices, like continuous glucose monitors, that utilize AI technology to assist in managing patients' health. Key provisions of the legislation require the Secretary of Health and Human Services to issue guidance by January 1, 2027.